Early detection of brain cancer will help saving lives. The currently available diagnostic techniques are not robust and expensive. Therefore, it is necessary to develop cost effective, minimally invasive, and highly sensitive analytical tools to identify brain tumors at an early stage. In this study we are investigating metabolism based biomarkers in platelets derived from low grade glioma II, glioblastoma, and healthy patients identified by nuclear magnetic resonance (NMR) spectroscopy. The platelet metabolites - glucose, citrate, and succinate are determined to be promising candidates for identifying and differentiating different stages of brain tumors with implication of employing simple blood based NMR metabolomics for early detection of brain cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords